BioCentury
ARTICLE | Company News

Abbott infectious diseases news

August 3, 1998 7:00 AM UTC

Abbott said that manufacturing difficulties with its capsule formulation of Norvir ritonavir HIV protease inhibitor will result in an indefinite supply shortage. The company said that during routine ...